HHS nominee Tom Price faces insider trading accusations

HHS nominee Tom Price faces insider trading accusations, President-elect Donald Trump’s nominee to lead the Department of Health and Human Services bought shares in a medical device company last year and then introduced legislation in the House to help the company less than a week later, CBS News has confirmed.

The new revelations about Rep. Tom Price, first reported by CNN on Monday evening, raises new ethics concerns and questions about whether Price engaged in insider trading. This comes just days before he’s slated to testify at his Senate confirmation hearing on Wednesday.

For More
Share on Google Plus

About Oddepia

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.
Post a Comment